Related references
Note: Only part of the references are listed.Histone deacetylase 3 is required for maintenance of bone mass during aging
Meghan E. McGee-Lawrence et al.
BONE (2013)
The sclerostin-bone protein interactome
Hemamalini Devarajan-Ketha et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Targeted deletion of Sost distal enhancer increases bone formation and bone mass
Nicole M. Collette et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sclerostin binds and regulates the activity of cysteine-rich protein 61
Theodore A. Craig et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Sclerostin-erbB-3 interactions: Modulation of erbB-3 activity by sclerostin
Theodore A. Craig et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
Renata C. Pereira et al.
BONE (2009)
Characterization of the Structural Features and Interactions of Sclerostin MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION
Vaclav Veverka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling
Chuwen Lin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Novel Mechanisms in the Regulation of Phosphorus Homeostasis
Theresa Berndt et al.
PHYSIOLOGY (2009)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST
Mikhail V. Semenov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
TGFβ inducible early gene-1 knockout mice display defects in bone strength and microarchitecture
Sabine F. Bensamoun et al.
BONE (2006)
Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity
Debra L. Ellies et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins
DG Winkler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mapping quantitative trait loci for vertebral trabecular bone volume fraction and microarchitecture in mice
ML Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice
UIL Mödder et al.
ENDOCRINOLOGY (2004)
The phosphatonin pathway: New insights in phosphate homeostasis
SC Schiavi et al.
KIDNEY INTERNATIONAL (2004)
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation
MK Sutherland et al.
BONE (2004)
High-throughput engineering of the mouse genome coupled with high-resolution expression analysis
DM Valenzuela et al.
NATURE BIOTECHNOLOGY (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate
AE Bowe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
